TrialClinical and translational science2024

Population pharmacokinetic analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia.

Pavan Vaddady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.